A Merger, Weight Loss , and Bio-Defense: CALL, ARNA, AVII Small Cap Network The primary focus for ARNA these days is its weight loss drug lorcaserin which will come before the FDA in September. ARNA has been gaining value of late ... Read more »
Arena to license weight-loss drug to Eisai – MarketWatch
Arena to license weight-loss drug to Eisai MarketWatch LONDON (MarketWatch) -- Arena Pharamceuticals (NASDAQ:ARNA) said it's granted Eisai Inc. Read more »
Can Investors Fatten Up On Weight Loss? – Investopedia
Can Investors Fatten Up On Weight Loss ? Investopedia Ever since the FDA pulled products containing ephedra off the market, there has been a dearth of proven over-the-counter options for weight loss . .. Read more »
